Skip to content

Author

M. Garhewal

We have 3 of 7 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Aug 2026

Design of Quinazoline Dual Inhibitors Targeting Focal Adhesion Kinase and Polo-like Kinase 1 for Metastatic Cancers: QSAR, Pharmacophore Modelling, and Molecular Docking Approaches.

INTRODUCTION FAK and PLK1 are regulators of oncogenic signaling and metastasis, and their coinhibition offers a synergistic anticancer strategy. This study employed computational modeling to design quinazoline-based scaffolds as potential dual FAK-PLK1 inhibitors. METHODS 54 quinazoline derivatives were analyzed usin...

M. Garhewal, Dipti Pal, A. K. Gupta et al. · 0 citations
Open access Aug 2026

2D-QSAR Modeling of Quinazoline Derivatives as EGFR Inhibitors for Colorectal Cancer

Background: Globally, colorectal cancer represents one of the most common types of cancer, along with being one of the top 10 causes of cancer-related deaths. Epidermal Growth Factor Receptors (EGFRs) are a major target for colorectal cancer, and quinazoline derivatives have shown anticancer activity as EGFR inhibitors...

Rishab Pathak, M. Garhewal, S. Yadav et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.